WMT

119.15

-0.72%↓

COST

955.8

+0.5%↑

TGT

111.2

+1.38%↑

62.5

+0.1%↑

DG.US

151.72

+0.6%↑

WMT

119.15

-0.72%↓

COST

955.8

+0.5%↑

TGT

111.2

+1.38%↑

62.5

+0.1%↑

DG.US

151.72

+0.6%↑

WMT

119.15

-0.72%↓

COST

955.8

+0.5%↑

TGT

111.2

+1.38%↑

62.5

+0.1%↑

DG.US

151.72

+0.6%↑

WMT

119.15

-0.72%↓

COST

955.8

+0.5%↑

TGT

111.2

+1.38%↑

62.5

+0.1%↑

DG.US

151.72

+0.6%↑

WMT

119.15

-0.72%↓

COST

955.8

+0.5%↑

TGT

111.2

+1.38%↑

62.5

+0.1%↑

DG.US

151.72

+0.6%↑

Home・Akciju saraksts・Lifecore Biomedical Inc

Lifecore Biomedical Inc

Slēgts

SektorsPatēriņa aizsardzības

8.06 2.41

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

7.6

Max

8.13

Galvenie mērījumi
By Trading Economics
Ienākumi	-7.9M -10M
Pārdošana	-5.3M 31M
Peļņas marža	-32.116
Darbinieki	406

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 16. janv.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	3.7M 245M
Iepriekšējā atvēršanas cena	5.65
Iepriekšējā slēgšanas cena	8.06

Lifecore Biomedical Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 15. janv. 18:44 UTC

Galvenie tirgus virzītāji

Agenus Falls After $141 Million Zydus Deal Closes

2026. g. 15. janv. 17:51 UTC

Galvenie tirgus virzītāji

Galaxy Digital Climbs on Texas Data-Center Expansion Approval, Tokenized CLO Issuance

2026. g. 15. janv. 17:25 UTC

Galvenie tirgus virzītāji

ASML Exceeds $500 Billion in Market Value on TSMC's Blockbuster Spending Plans -- Update

2026. g. 15. janv. 23:48 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 15. janv. 23:48 UTC

Tirgus saruna

Nikkei May Decline as Enthusiasm Over Election Eases -- Market Talk

2026. g. 15. janv. 23:40 UTC

Tirgus saruna

Gold Edges Lower Amid Abating Geopolitical Risks -- Market Talk

2026. g. 15. janv. 23:11 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 15. janv. 23:11 UTC

Tirgus saruna

Ryman Healthcare's Resales Remain Key Concern -- Market Talk

2026. g. 15. janv. 23:01 UTC

Tirgus saruna

New Zealand's Economy Enters An Upswing -- Market Talk

2026. g. 15. janv. 22:56 UTC

Tirgus saruna

Peļņas

Catalyst Metals Delivers a Beat With Record Gold Output -- Market Talk

2026. g. 15. janv. 22:51 UTC

Tirgus saruna

James Hardie's Plant Closures Could Boost Profit by 2%-3% -- Market Talk

2026. g. 15. janv. 22:19 UTC

Iegādes, apvienošanās, pārņemšana

Verizon Gets Final California Approval to Secure $9.6 Billion Frontier Deal -- WSJ

2026. g. 15. janv. 21:50 UTC

Tirgus saruna

Peļņas

Financial Services Roundup: Market Talk

2026. g. 15. janv. 21:50 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Energy & Utilities Roundup: Market Talk

2026. g. 15. janv. 21:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 15. janv. 21:27 UTC

Peļņas

BlackRock Caps 2025 With Record $14 Trillion in Assets -- 3rd Update

2026. g. 15. janv. 21:15 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Global Commodities Roundup: Market Talk

2026. g. 15. janv. 21:11 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Global Equities Roundup: Market Talk

2026. g. 15. janv. 21:11 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Canada Antitrust Watchdog Confirms Review of Canadian Energy Deal -- Market Talk

2026. g. 15. janv. 20:10 UTC

Tirgus saruna

U.S. Natural Gas Futures Settle Mixed -- Market Talk

2026. g. 15. janv. 20:04 UTC

Peļņas

These Stocks Are Today's Movers: TSMC, ASML, Goldman, Morgan Stanley, BlackRock, Coinbase, Sandisk, and More -- Barrons.com

2026. g. 15. janv. 20:03 UTC

Tirgus saruna

Oil Futures Fall As Iran Risk Premium Fades -- Market Talk

2026. g. 15. janv. 19:26 UTC

Tirgus saruna

Silver Closes at Fresh High -- Market Talk

2026. g. 15. janv. 18:29 UTC

Galvenie tirgus virzītāji

Agenus Falls After $141M Zydus Deal Closes

2026. g. 15. janv. 18:20 UTC

Peļņas

Wall Street Powers Nation's Biggest Banks to Record Year -- WSJ

2026. g. 15. janv. 17:56 UTC

Tirgus saruna

Peļņas

U.S. Bank Results Look Encouraging for European Peers -- Market Talk

2026. g. 15. janv. 17:20 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Auto & Transport Roundup: Market Talk

2026. g. 15. janv. 17:20 UTC

Tirgus saruna

Health Care Roundup: Market Talk

2026. g. 15. janv. 17:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2026. g. 15. janv. 17:02 UTC

Iegādes, apvienošanās, pārņemšana

KBC Group Completes Acquisition of 98.45% Stake in 365.bank From J&T Finance Group

Salīdzinājums

Cenas izmaiņa

Lifecore Biomedical Inc Prognoze

Vērtējuma vienprātība

By TipRanks

Pirkt

4 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 4 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Lifecore Biomedical Inc — pēdējo 3 mēnešu laikā.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Lifecore Biomedical Inc

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.